Epratuzumab (Anti-Siglec-2 / CD22)Epratuzumab (Anti-Siglec-2 / CD22)
Move your mouse over image or click to enlarge

Epratuzumab (Anti-Siglec-2 / CD22)

Epratuzumab (Anti-Siglec-2 / CD22) is a IgG1 monoclonal antibody targeting CD22. It has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases. MW: 155.4 KD.
Cat# Size Price Qty Buy
A3056-1mg*25 1mg*25
£2,432.00
A3056-1mg*5 1mg*5
£794.00
A3056-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A3056

Related Documents